However, data regarding it's prognostic role in early breast cancer remain controversial, with some studies reporting an adverse impact of IGF1R overexpression on clinical outcomes [16]–[18] and others suggesting a favorable prognostic role [19]–[22]. This evidence concerns the gene IGF1R and breast cancer.